The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and ...

The modern food system is largely dependent on a limited genetic pool of crops, raising significant concerns about ...

Climb Bio’s inclusion in the Nasdaq Biotechnology Index will be effective prior to market open on Monday, December 23, 2024.

On Monday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $1.63 which represents a decrease of $-0.02 or -1.21% from the prior close of $1.65. The stock opened at $1.65 and ...

The latest authorization bill pushes the intelligence community to boost many of its workforce and tech efforts, including its public-private talent exchange.

Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at ...

A recent perspective unveils the potential of using virus-based biotechnologies to improve the performance and diversity of ...

Earlier this week, efforts to reduce U.S. reliance on biotechnology companies in China stalled when the BIOSECURE Act (“BIOSECURE” or the “Act”) ...

Union Minister Dr. Jitendra Singh emphasized the transformative impact of BRIC in consolidating governance across 14 of India ...

Middlemen get a bad rap for adding cost and complications to an operation. So, eliminating the go-betweens can reduce expense ...

Spyre Therapeutics (SYRE) announced Spyre has been added to the Nasdaq Biotechnology Index effective prior to market open, Monday, December 23.